Pages that link to "Q34974856"

The following pages link to The therapeutic potential of the cannabinoids in neuroprotection (Q34974856):

Displaying 26 items.

• Cannabinoids for the treatment of dementia (Q24241582) (← links)
• Cannabinoids for the treatment of dementia (Q24242873) (← links)
• The endocannabinoid system as an emerging target of pharmacotherapy (Q24648473) (← links)
• The therapeutic potential of cannabis (Q34212503) (← links)
• Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271 (Q34266329) (← links)
• Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors (Q34278963) (← links)
• The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats (Q34472972) (← links)
• Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance (Q34581675) (← links)
• Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo (Q34858094) (← links)
• Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? (Q34967151) (← links)
• The therapeutic potential of cannabis in multiple sclerosis (Q35094657) (← links)
• Remyelinating and neuroprotective treatments in multiple sclerosis (Q35753458) (← links)
• Drugs of abuse and the aging brain (Q36779439) (← links)
• Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence (Q36787826) (← links)
• Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users (Q36829594) (← links)
• Cannabinoids and neuroprotection in basal ganglia disorders. (Q36977766) (← links)
• Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model (Q37087780) (← links)
• Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways. (Q38287134) (← links)
• Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach (Q38615088) (← links)
• Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells. (Q39834593) (← links)
• Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects. (Q45176545) (← links)
• Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms (Q46426378) (← links)
• The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis (Q48097673) (← links)
• The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic? (Q51980131) (← links)
• Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives (Q92310219) (← links)
• Cannabinoids for the treatment of dementia (Q94337892) (← links)